|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash | |||||||||||
| Deferred offering costs | |||||||||||
| Prepaid expenses | |||||||||||
| Due from related parties | |||||||||||
| Related Party | |||||||||||
| Total due from related parties | |||||||||||
| Total current assets | |||||||||||
| Deferred financing costs | |||||||||||
| Total assets | |||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Trade accounts payable and accrued liabilities | |||||||||||
| Due to officer | |||||||||||
| Due to related parties | |||||||||||
| Officer | |||||||||||
| Related Party | |||||||||||
| Total due to related parties | |||||||||||
| Related party line of credit | |||||||||||
| Accrued compensation - officer | |||||||||||
| Insurance loan payable | |||||||||||
| Total current liabilities | |||||||||||
| Total liabilities | |||||||||||
| Stockholders’ Equity: | |||||||||||
| Additional paid-in capital | |||||||||||
| Accumulated deficit | |||||||||||
| Total stockholders’ equity | |||||||||||
| Total liabilities and stockholders’ equity |
Loading...
